Results 41 to 50 of about 242,918 (218)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

BMC Cancer, 2018
Background Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1–3 or 1–5 metastases in number.
Robert Olson, Mitchell Liu, Alanah Bergman, Sonya Lam, Fred Hsu, Benjamin Mou, Tanya Berrang, Ante Mestrovic, Nick Chng, Derek Hyde, Quinn Matthews, Chad Lund, Daniel Glick, Howard Pai, Parminder Basran, Hannah Carolan, Boris Valev, Shilo Lefresene, Scott Tyldesley, Devin Schellenberg   +19 more
doaj   +1 more source

Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience

Open Heart, 2021
Background Options for patients with ventricular tachycardia (VT) refractory to antiarrhythmic drugs and/or catheter ablation remain limited. Stereotactic radiotherapy has been described as a novel treatment option.Methods Seven patients with recurrent ...
Justin Lee, Nicholas Kelland, Neil Seller, Matthew Bates, Matthew Hatton, Nicholas Child, Andrew Thornley, Ewen Shepherd, Stephen Riley, Peter Metherall, Michael Henshaw, Jim Daniel, Alison Blower, David Scoones, Michele Wilkinson, Neil Richmond, Clifford Robinson, Phillip Cuculich, Geoffrey Hugo, Ruth McStay, Philip Atherton, Clive Peedell   +21 more
doaj   +1 more source

A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma. [PDF]

Dis Model Mech
Liver tumours, both primary and metastatic, are diseases of unmet clinical need. Hepatocellular carcinoma (HCC), the most common primary liver tumour, like many other cancers, can be treated by stereotactic ablative radiotherapy (SABR), reducing off ...
May S, Stevenson K, Alqarafi B, Yin Swe KL, Bloom A, Mackintosh A, Müller M, Georgakopoulou A, Drake TM, Kiourtis C, Karim SA, Nixon C, Cadden B, Duffton A, Grose D, Lewis DY, Blyth K, Chalmers AJ, Bird TG.   +18 more
europepmc   +2 more sources

Stereotactic ablative radiotherapy in the UK: current status and developments [PDF]

The British Journal of Radiology, 2013
Stereotactic ablative radiotherapy (SABR) has developed from the principles and techniques used in the stereotactic radiosurgery treatment of brain metastases. Advances in computer technology, imaging, planning and treatment delivery and evidence from retrospective analysis of single- and multi-institutional early-phase studies have established SABR in
P, Jain, A, Baker, G, Distefano, A J D, Scott, G J, Webster, M Q, Hatton   +5 more
openaire   +2 more sources

Biomarkers in Stereotactic Ablative Radiotherapy: Current Evidence and Future Directions. [PDF]

Int J Mol Sci
Stereotactic ablative radiotherapy (SABR) has revolutionized the management of patients with oligometastatic and selected primary cancers due to its ability to deliver highly conformal, high-dose radiation in few fractions with minimal toxicity. However,
Metawe M, Mikropoulos C, Al-Sattar H, Sood I, Jaafari AM, Galante JR, Adeleke S.   +6 more
europepmc   +2 more sources

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

Clinical and Translational Radiation Oncology, 2019
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle, Nicolaus Andratschke, Shankar Siva, Matthias Guckenberger   +3 more
doaj   +1 more source

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases [PDF]

Japanese Journal of Clinical Oncology, 2018
There is growing interest in the use of stereotactic ablative radiotherapy (SABR) for oligometastases. However, extreme caution should be exercised in treating tumors closely located to organs at risk (OARs) with SABR. To reduce complications, we have applied split-course SABR to oligometastases closely located to OARs or to those being retreated with ...
Paik, Eun Kyung, Kim, Mi-Sook, Seo, Young-Seok, Jang, Won Il, Kang, Jin-Kyu, Cho, Chul-Koo, Yoo, Hyung Jun   +6 more
openaire   +2 more sources

An evaluation of systematic errors on marker-based registration of computed tomography and magnetic resonance images of the liver

Physics and Imaging in Radiation Oncology, 2018
We demonstrated a general method to evaluate systematic errors related to Magnetic Resonance (MR) imaging sequences in marker-based co-registration of MR and Computed Tomography (CT) images, and investigated the effect of MR image quality in the co ...
Thomas Woolcot, Evanthia Kousi, Emma Wells, Katharine Aitken, Helen Taylor, Maria A. Schmidt   +5 more
doaj   +1 more source

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

Frontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani, Giovanni eAguzzi, David eSchaal, Pantaleo eRomanelli   +3 more
doaj   +1 more source

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report

JTO Clinical and Research Reports, 2022
Stereotactic ablative radiotherapy (SABR) is a highly effective treatment for medically inoperable patients with early stage NSCLC. Because of its noninvasive nature and favorable toxicity profile, the use of SABR continues to expand for eligible ...
Ha H. Pham, MD, PhD, Neil Newman, MD, Evan C. Osmundson, MD, PhD   +2 more
doaj   +1 more source